Literature DB >> 16737784

T-box proteins differentially activate the expression of the endogenous interferon gamma gene versus transfected reporter genes in non-immune cells.

Nataliya V Butz1, Richard M Gronostajski, Christine E Campbell.   

Abstract

The T-box transcription factor T-bet is expressed in a number of hematopoetic cell types and plays an essential role in the lineage determination of Th1 T-helper cells. In the absence of T-bet, CD4(+) T-cells fail to induce IFNgamma, the cytokine whose expression characterizes Th1 cells. Here we show that, surprisingly, T-bet induces the expression of endogenous IFNgamma in non-immune human cells, including 293 and other cell lines. Thus T-bet can induce IFNgamma expression independently of its role in T-cell lineage determination. In addition, mutations in T-bet, and chimeras of T-bet with other transcription factors including the T-box transcription factor, TBX2, differentially affect the ability of T-bet to activate expression of endogenous IFNgamma versus a T-site regulated reporter gene. A truncated T-betVp16 fusion protein strongly activates the T-site reporter but fails to activate endogenous IFNgamma. Conversely, native T-bet strongly activates endogenous IFNgamma expression but only weakly activates the reporter gene. Fusion of the Vp16 activation domain to full-length T-bet greatly increases its activation of both endogenous IFNgamma and transfected T-site reporter gene expression. In contrast, TBX2Vp16 potently activates the T-site reporter but has a negligible effect on endogenous IFNgamma expression. Butyrate treatment of T-bet expressing cells potentiates the expression of endogenous IFNgamma but weakly represses expression of the T-site reporter gene. These data indicate that induction of endogenous IFNgamma can be uncoupled from differentiation into the Th1 lineage and that the expression of endogenous IFNgamma versus a T-site reporter gene is differentially regulated by T-bet and other T-box proteins.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16737784     DOI: 10.1016/j.gene.2006.03.016

Source DB:  PubMed          Journal:  Gene        ISSN: 0378-1119            Impact factor:   3.688


  4 in total

Review 1.  Common themes emerge in the transcriptional control of T helper and developmental cell fate decisions regulated by the T-box, GATA and ROR families.

Authors:  Sara A Miller; Amy S Weinmann
Journal:  Immunology       Date:  2009-03       Impact factor: 7.397

2.  c-Abl-mediated tyrosine phosphorylation of the T-bet DNA-binding domain regulates CD4+ T-cell differentiation and allergic lung inflammation.

Authors:  An Chen; Sang-Myeong Lee; Beixue Gao; Stephen Shannon; Zhou Zhu; Deyu Fang
Journal:  Mol Cell Biol       Date:  2011-06-20       Impact factor: 4.272

3.  Genome-wide association analysis identifies three new risk loci for gout arthritis in Han Chinese.

Authors:  Changgui Li; Zhiqiang Li; Shiguo Liu; Can Wang; Lin Han; Lingling Cui; Jingguo Zhou; Hejian Zou; Zhen Liu; Jianhua Chen; Xiaoyu Cheng; Zhaowei Zhou; Chengcheng Ding; Meng Wang; Tong Chen; Ying Cui; Hongmei He; Keke Zhang; Congcong Yin; Yunlong Wang; Shichao Xing; Baojie Li; Jue Ji; Zhaotong Jia; Lidan Ma; Jiapeng Niu; Ying Xin; Tian Liu; Nan Chu; Qing Yu; Wei Ren; Xuefeng Wang; Aiqing Zhang; Yuping Sun; Haili Wang; Jie Lu; Yuanyuan Li; Yufeng Qing; Gang Chen; Yangang Wang; Li Zhou; Haitao Niu; Jun Liang; Qian Dong; Xinde Li; Qing-Sheng Mi; Yongyong Shi
Journal:  Nat Commun       Date:  2015-05-13       Impact factor: 14.919

4.  Identification of a novel mechanism of action of fingolimod (FTY720) on human effector T cell function through TCF-1 upregulation.

Authors:  Maria Antonietta Mazzola; Radhika Raheja; Gopal Murugaiyan; Hasan Rajabi; Deepak Kumar; Thomas Pertel; Keren Regev; Russell Griffin; Lilian Aly; Pia Kivisakk; Parham Nejad; Bonny Patel; Nguendab Gwanyalla; Hillary Hei; Bonnie Glanz; Tanuja Chitnis; Howard L Weiner; Roopali Gandhi
Journal:  J Neuroinflammation       Date:  2015-12-30       Impact factor: 8.322

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.